<DOC>
	<DOCNO>NCT01518959</DOCNO>
	<brief_summary>Recent data show inadequate vitamin D status play role manifestation haematologic tumor serum vitamin D level prognostic role also determine tumor mortality . But data prove causal relationship inadequate vitamin D status unfavourable outcomes far . It also still unknown , whether normalization vitamin D status patient vitamin D inadequacy able improve prognosis survival . In study investigator examine role adequate vitamin D substitution improvement outcomes haematologic disorder .</brief_summary>
	<brief_title>The Effect 25-OH-Vitamin-D3 Substitution Patients With Malignant Immune-hematologic Diseases</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<mesh_term>Leukemia , Lymphocytic , Chronic , B-Cell</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>least 18 year old male female chronic lymphoid leukaemia , Rai stage 25OHVitaminD3 level 10 30 ng/mL serum calcium &gt; 2,60 mmol/l 24 hour calcium urine excretion &gt; 0,1 mmol/kg/day serum phosphate &gt; 1,45 mmol/l eGFR &lt; 30 ml/min/1,73m2 nephrolithiasis receive parenteral vitaminD3 past 6 month activate vitaminD3 treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>